Efficacy of Dupilumab for Severe Atopic Dermatitis Co-occurring With Asthma in a Real-World Setting

被引:3
|
作者
Pose, K. [1 ]
Laorden, D. [2 ]
Hernandez, N. [3 ]
Villamanan, E. [4 ]
Quirce, S. [1 ,5 ,6 ]
Dominguez-Ortega, J. [1 ,5 ,6 ]
机构
[1] La Paz Univ Hosp, Dept Allergy, Madrid, Spain
[2] La Paz Univ Hosp, Dept Pulmonol, Madrid, Spain
[3] La Paz Univ Hosp, Dept Dermatol, Madrid, Spain
[4] La Paz Univ Hosp, Dept Hosp Pharm, Madrid, Spain
[5] La Paz Inst Hlth Res IdiPAZ, Madrid, Spain
[6] CIBER Resp Dis CIBERES, Madrid, Spain
关键词
Dupilumab; Asthma; Severe atopic dermatitis; Type 2 inflammatory diseases; IL-13;
D O I
10.18176/jiaci.0837
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:217 / 219
页数:3
相关论文
共 50 条
  • [11] Efficacy and Safety of Dupilumab in Chinese Elderly Patients with Atopic Dermatitis: A Real-World Study
    Hu, Yu-Qing
    Zhang, Jian-Zhong
    Zhao, Yan
    DERMATOLOGY, 2024, 240 (04) : 589 - 596
  • [12] Real-world efficacy and safety of dupilumab for paediatric atopic dermatitis: a multicentre retrospective study
    Pirov, Eitan
    Molho-Pessach, Vered
    Cohen-Barak, Eran
    Levitt, Jen A. Barak
    Barzilai, Aviv
    Bar, Jonathan
    Renert-Yuval, Yael
    Bar-Ilan, Efrat
    Friedland, Rivka
    Greenberger, Shoshana
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024,
  • [13] DUPILUMAB SAFETY AND EFFICACY IN A REAL-WORLD CLINICAL SETTING: THE RAPID ASTHMA REGISTRY
    Peters, Anju T.
    Hilberg, Ole
    Lugogo, Njira L.
    Ramsey, Allison C.
    Shao, Liyang
    Gomez, Lucia De Prado
    Jacob-Nara, Juby A.
    Sacks, Harry
    Rowe, Paul J.
    Deniz, Yamo
    Gall, Rebecca
    CHEST, 2024, 166 (04) : 6457A - 6460A
  • [14] TREATGermany registry: "real-world effectiveness" of dupilumab in atopic dermatitis
    Weidinger, S.
    Stoelzl, D.
    Abraham, S.
    Haufe, E.
    Heratizadeh, A.
    Werfel, T.
    Schmitt, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S236 - S236
  • [15] Real-world persistence with dupilumab among adults with atopic dermatitis
    Silverberg, Jonathan I.
    Guttman-Yassky, Emma
    Gadkari, Abhijit
    Kuznik, Andreas
    Mallya, Usha G.
    Mastey, Vera
    Zhang, Haixin
    Chen, Zhen
    Chen, Cheng
    Korotzer, Andrew
    Sierka, Debra
    Fenton, Miriam C.
    Kaur, Mandeep
    Jalbert, Jessica J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (01) : 40 - 45
  • [16] Comprehensive real-world comparisons between baricitinib and dupilumab treatments for moderate severe atopic dermatitis
    Cho, Yung-Tsu
    Lee, Meng-Sui
    Chang, Wen -Yu
    Lu, Yea-Ting
    Chu, Chia -Yu
    Chan, Tom C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (07): : 1924 - 1927.e1
  • [17] Real-world efficacy of dupilumab re-administration after discontinuation in patients with atopic dermatitis
    Matsutani, Masako
    Imai, Yasutomo
    Miyamoto, Shoko
    Inoue, Yukako
    Natsuaki, Masaru
    Kanazawa, Nobuo
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2024, 7
  • [18] Efficacy of dupilumab in real practice in the treatment of severe forms of asthma and atopic dermatitis (comparative retrospective study)
    Fomina, Daria S.
    Fedosenko, Sergey. V.
    Bobrikova, Elena N.
    Chernov, Anton A.
    Mukhina, Olga A.
    Lebedkina, Marina S.
    Karaulov, Alexander. V.
    Nurtazina, Asel Yu.
    Lysenko, Mariana A.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (07) : 568 - 573
  • [19] Real-world persistence with dupilumab among adults with atopic dermatitis (AD)
    Silverberg, J.
    Guttman-Yassky, E.
    Gadkari, A.
    Kuznik, A.
    Mallya, U. G.
    Mastey, V.
    Zhang, H.
    Chen, Z.
    Chen, C.
    Korotzer, A.
    Sierka, D.
    Fenton, M. C.
    Kaur, M.
    Jalbert, J. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S116 - S116
  • [20] Real-world use of dupilumab for 53 patients with atopic dermatitis in Japan
    Matsutani, Masako
    Imai, Yasutomo
    Inoue, Yukako
    Hosotani, Yuka
    Kusakabe, Minori
    Natsuaki, Masaru
    Yamanishi, Kiyofumi
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2020, 3 (02) : 35 - 36